Role of mercury toxicity in hypertension, cardiovascular disease, and stroke

Journal of Clinical Hypertension

Volumn 13, Issue 8, 2011, Pages 621-627

  Houston, Mark C ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hypertension Institute and Vacular Biology   (United States)

^c SAINT THOMAS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; MERCURY; OMEGA 3 FATTY ACID;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HEART ARRHYTHMIA; HEART INFARCTION; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MERCURIALISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; REVIEW; STROKE; THROMBOSIS;

CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; MERCURY; MITOCHONDRIA; OXIDATIVE STRESS; STROKE;

EID: 79960935974     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00489.x     Document Type: Review

References (70)

1. Keating MH, Mahaffey KR, Schoemy R, et al. Mercury Study Report to Congress. Vol. I. Executive Summary. EPA-452/R-97-003. Washington, D.C.: Environmental Protection Agency, December 1997.
2. Committee on the Toxicological Effects of Methylmercury, Board on Environmental Studies and Toxicology, Commission on Life Sciences. Toxicological Effects of Methylmercury. Washington, D.C.: National Research Council, 2000.
3. Magos L. Physiology and toxicology of mercury. Met Ions Biol Syst. 1997;34:321-370.
4. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury - current exposures and clinical manifestations. N Engl J Med. 2003;349:1731-1737.
5. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347:1747-1754.
6. Ahlqwist M, Bengtsson C, Lapidus L, et al. Serum mercury concentration in relation to survival, symptoms, and diseases: results from the prospective population study of women in Gothenburg, Sweden. Acta Odontol Scand. 1999;57:168-174.
7. Bergdahl IA, Schutz A, Ahlqwist M, et al. Methylmercury and inorganic mercury in serum - correlation to fish consumption and dental amalgam in a cohort of women born in 1922. Environ Res. 1998;77:20-24.
8. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91:645-655.
9. Yoshizawa K, Rimm EB, Morris JS, et al. Mercury and the risk of coronary heart disease in men. N Engl J Med. 2002;347:1755-1760.
10. Chmielnicka J, Bem EM, Kaszubski P. Organ and subcellular distribution of cadmium in rats exposed to cadmium, mercury, and selenium. Environ Res. 1983;31:266-272.
11. Komsta-Szumska E, Chmielnicka J. Effects of zinc, cadmium or copper on mercury distribution in rat tissues. Toxicol Lett. 1983;17:349-354.
12. International Programme on Chemical Safety (IPCS). Methylmercury. Environmental Health Criteria 101. Geneva, Switzerland: World Health Organization; 1990.
13. Salonen JT, Seppanen K, Lakka TA, et al. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148:265-273.
14. Parizek J, Ostadalova I. The protective effect of small amounts of selenite in sublimate intoxication. Experientia. 1967;23:142-143.
15. Ganther HE, Goudie C, Sunde ML, et al. Selenium: relation to decreased toxicity of methylmercury added to diets containing tuna. Science. 1972;175:1122-1124.
16. Ganther HE, Sunde ML. Effect of tuna fish and selenium on the toxicity of methylmercury: a progress report. J Food Sci. 1974;39:1-5.
17. Stoewsand GS, Bache CA, Lisk DJ. Dietary selenium protection of methylmercury intoxication of Japanese quail. Bull Environ Contam Toxicol. 1974;11:152-156.
18. Sumino K, Yamamoto R, Kitamura SA. Role of selenium against methylmercury toxicity. Nature. 1977;268:73-74.
19. Singhal RK, Anderson ME, Meister A. Glutathione, a first line of defense against cadmium toxicity. FASEB J. 1987;1:220-223.
20. Seppanen K, Kantola M, Laatikainen R, et al. Effect of supplementation with organic selenium on mercury status as measured by mercury in pubic hair. J Trace Elem Med Biol. 2000;14:84-89.
21. 2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45:2017-2024.
22. Shenker BJ, Guo TL, Shapiro IM. Low-level methylmercury exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial dysfunction. Environ Res. 1998;77:149-159.
23. Jansson G, Harms-Ringdahl M. Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic Res Commun. 1993;18:87-98.
24. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci. 1997;34:369-403.
25. Insug O, Datar S, Koch CJ, et al. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology. 1997;124:211-224.
26. Wiggers GA, Pecanha FM, Briones AM, et al. Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteries. Am J Physiol Heart Circ Physiol. 2008;295:H1033-H1043.
27. Kobal AB, Horvat M, Prezelj M, et al. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol. 2004;17:261-274.
28. Park ST, Lim KT, Chung YT, et al. Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Neurotoxicology. 1996;17:37-45.
29. Miller DM, Lund BO, Woods JS. Reactivity of Hg(II) with superoxide: evidence for the catalytic dismutation of superoxide by Hg(II). J Biochem Toxicol. 1991;6:293-298.
30. Naganuma A, Koyama Y, Imura N. Behavior of methylmercury in mammalian erythrocytes. Toxicol Appl Pharmacol. 1980;54:405-410.
31. Cuvin-Aralar ML, Furness RW. Mercury and selenium interaction: a review. Ecotoxicol Environ Saf. 1991;21:348-364.
32. Rungby J, Ernst E. Experimentally induced lipid peroxidation after exposure to chromium, mercury or silver: interactions with carbon tetrachloride. Pharmacol Toxicol. 1992;70:205-207.
33. Lin TH, Huang YL, Huang SF. Lipid peroxidation of rats administered with methyl mercuric chloride. Biol Trace Elem Res. 1996;54:33-41.
34. Wierzbicki R, Prazanowski M, Michalska M, et al. Disorders in blood coagulation in humans occupationally exposed to mercuric vapors. J Trace Elem Exp Med. 2002;15:21-29.
35. Kishimoto T, Oguri T, Abe M, et al. Inhibitory effect of methylmercury on migration and tube formation by cultured human vascular endothelial cells. Arch Toxicol. 1995;69:357-361.
36. Lu KP, Zhao SH, Wang DS. The stimulatory effect of heavy metal cations on proliferation of aortic smooth muscle cells. Sci China B. 1990;33:303-310.
37. Gonzalvo MC, Gil F, Hernandez AF, et al. Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chem Biol Interact. 1997;105:169-179.
38. Salonen JT, Malin R, Tuomainen TP, et al. Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. BMJ. 1999;319:487-488.
39. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58:461-466.
40. Torres AD, Rai AN, Hardiek ML. Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics. 2000;105:E34.
41. Barregard L, Sallsten G, Jarvholm B. Mortality and cancer incidence in chloralkali workers exposed to inorganic mercury. Br J Ind Med. 1990;47:99-104.
42. Wojciechowski J, Kowalski W. Cardiac and aortic lesions in chronic experimental poisoning with mercury vapors. Pol Med Sci Hist Bull. 1975;15:255-260.
43. Rissanen T, Voutilainen S, Nyyssonen K, et al. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation. 2000;102:2677-2679.
44. Kobal AB, Flisar Z, Miklavcic V, et al. Renal function in miners intermittently exposed to elemental mercury vapour. Arh Hig Rada Toksikol. 2000;51:369-380.
45. Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr. 2000;71:171S-175S.
46. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet. 1989;2:757-761.
47. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.
48. Marckmann P, Gronback M. Fish consumption and coronary heart disease mortality: a systemic review of prospective cohort studies. Eur J Clin Nutr. 1999;53:585-590.
49. MacIntosh DL, Williams PL, Hunter DJ, et al. Evaluation of a food frequency questionnaire-food composition approach for estimating dietary intake of inorganic arsenic and methylmercury. Cancer Epidemiol Biomarkers Prev. 1997;6:1043-1050.
50. Garland M, Morris JS, Rosner BA, et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev. 1993;2:493-497.
51. Mazerik JN, Mikkilineni H, Kuppusamy VA, et al. Mercury activates phospholipase a (2) and induces formation of arachidonic acid metabolities in vascular endolthelial cells. Toxicol Mech Methods. 2007;17:541-557. 55.
52. Mazerik JN, Hagele T, Sherwani S, et al. Phospholipase A 2 activation regulates cytotoxicity of methylmercury in vascular endothelial cells. Int J Toxicol. 2007;26:553-569.
53. Hagele TJ, Mazerik JN, Gregory A, et al. Mercury activates vascular endothelial cell phospholipase D through thiols and oxidative stress. Int J Toxicol. 2007;26:57-69.
54. Peltz A, Sherwani SI, Kotha SR, et al. Calcium and calmodulin regulate mercury-induced phospholipase D activation in vascular endothelial cells. Int J Toxicol. 2009;28:190-206.
55. Al-Saleh I, Shinwari N, Mashhour A, et al. Cadmium and mercury levels in Saudi women and its possible relationship with hypertension. Biol Trace Elem Res. 2006;112:13-29.
56. Fillion M, Mergler D, Sousa Passos CJ, et al. A preliminary study of mercury exposure and blood pressure in the Brazilian Amazon. Environ Health. 2006;5:29-46.
57. Bautista LE, Stein JH, Morgan BJ, et al. Association of blood and hair mercury with blood pressure and vascular reactivity. WMJ. 2009;108:250-252.
58. Valera B, Dewailly E, Poirier P. Environmental mercury exposure and blood pressure among Nunavik Inuit adults. Hypertension. 2009;54:981-986.
59. Yorifugi T, Tsuda T, Kashima S, et al. Long-term exposure to methylmercury and its effects on hypertension in Minamata. Environ Res. 2010;110:40-46.
60. Vupputuri S, Longnecker MP, Daniels JL, et al. Blood mercury level and blood pressure among US women: results from the National Health and Nutrition Examination Survey 1999-2000. Environ Res. 2005;97:195-200.
61. Moszczynski P. Mercury and the risk of coronary heart disease. Przegl Lek. 2006;63(Suppl. 7):84-87.
62. Virtanen JK, Rissanen TH, Boutilainen S, et al. Mercury as a risk factor for cardiovascular diseases. J Nutr Biochem. 2007;18:75-85.
63. Smith KM, Barraj LM, Kantor M, et al. Relationship between fish intake, n-3 fatty acids, mercury and risk of CHD (National Health and Nutrition Examination Survey 1999-2002). Public Health Nutr. 2009;12:1261-1269.
64. Skoczynska A, Jedrejko M, Martynowicz H, et al. The cardiovascular risk in chemical factory worker exposed to mercury vapor. Med Pr. 2010;61:381-391.
65. Wennberg M, Berdahl IA, Stegmayr B, et al. Fish intake, mercury, long chain n-3 polyunsaturated fatty acids and risk of stroke in northern Sweden. Br J Nutr. 2007;98:1038-1045.
66. Lim KM, Kim S, Kim K, et al. Low-level mercury can enhance procoagulant activity of erythrocytes: a new contributing factor for mercury-related thrombotic disease. Environ Health Perspect. 2010;118:928-935.
67. Pedersen EB, Jergensen ME, Pedersen MB, et al. Relationship between mercury in blood and 24-h ambulatory blood pressure in Geenlander and Danes. Am J Hypertens. 2005;18:612-618.
68. Garcia Gomez M, Boffetta P, Caballero K, et al. Cardiovascular mortality in mercury miners. Med Clin (Barc). 2007;128:766-771.
69. Choi AL, Weihe P, Budtz-Jorgensen E, et al. Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men. Environ Health Perspect. 2009;117:367-372.
70. Valera B, Dewailly E, Poirier P. Cardiac autonomic activity and blood pressure among Nunavik Inuit adults exposed to environmental mercury: a cross-sectional study. Environ Health. 2008;7:29-46.